Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

61.05
Delayed Data
As of May 22
 -0.37 / -0.60%
Today’s Change
47.36
Today|||52-Week Range
68.75
+6.16%
Year-to-Date

Today’s Trading

Previous close61.42
Today’s open61.28
Day’s range60.78 - 61.83
Volume2,906,501
Average volume (3 months)5,656,241
Market cap$58.9B
Dividend yield2.20%
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+2.05%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)-0.47%
P/E ratio19.0
Price/Sales2.42
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.51+2.52%
NEPTNeptune Technologies...+0.03+2.21%
VBLTVascular Biogenics L...+0.20+3.96%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$1.29
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers